Trial Profile
Clinical Trials Insight: 700032673
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2008
Price :
$35
*
At a glance
- Drugs Muromonab CD3 (Primary) ; Glucosylceramide
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Hadasit
- 17 Apr 2008 New trial record.